Category: Pharmaceutical Information - Page 3

Quality by Design in Generic Drug Development: Modern Science-Based Approaches

By Lindsey Smith    On 15 Dec, 2025    Comments (15)

blog-post-image

Quality by Design (QbD) transforms generic drug development by building quality into the process from the start. Learn how modern science-based approaches improve approval rates, reduce costs, and ensure bioequivalence without relying on end-product testing.

View More

Pharmacy Errors with Generics: Prevention and Correction Strategies

By Lindsey Smith    On 15 Dec, 2025    Comments (9)

blog-post-image

Generic medications are essential for affordable care, but they come with hidden risks. Learn how common pharmacy errors happen, why they occur, and what pharmacists and patients can do to prevent them.

View More

Digoxin Interactions: What Heart Patients Need to Monitor

By Lindsey Smith    On 15 Dec, 2025    Comments (15)

blog-post-image

Digoxin helps manage heart failure and atrial fibrillation, but its narrow safety window makes interactions dangerous. Learn which drugs, foods, and supplements can raise toxicity risk - and how to stay safe.

View More

How Government Controls Generic Drug Prices in the U.S. Today

By Lindsey Smith    On 8 Dec, 2025    Comments (12)

blog-post-image

The U.S. doesn't set generic drug prices directly, but Medicaid rebates, Medicare caps, and the 340B program help lower costs. Learn how government policies affect what you pay for generics today.

View More

Biosimilar Cost Savings: How They Compare to Original Biologic Prices

By Lindsey Smith    On 3 Dec, 2025    Comments (13)

blog-post-image

Biosimilars offer real cost savings on expensive biologic drugs, with up to 85% lower list prices in some cases. Learn how they compare to originators, why savings vary, and why adoption remains low despite billions in potential savings.

View More

How to Search FDA’s Drugs@FDA Database for Official Drug Information

By Lindsey Smith    On 1 Dec, 2025    Comments (13)

blog-post-image

Learn how to use FDA's Drugs@FDA database to find official drug approval information, labels, and regulatory documents. Free, no login required, updated daily.

View More

Digital Pill Sensors: How Adherence Insights and Side Effect Detection Are Changing Medication Management

By Lindsey Smith    On 26 Nov, 2025    Comments (7)

blog-post-image

Digital pill sensors track medication intake and detect early side effects using ingestible sensors and wearable patches. Used in mental health, HIV, and chronic disease care, they improve adherence but raise privacy and cost concerns.

View More

New Antidepressants with Better Side Effect Profiles: What’s Emerging in 2025

By Lindsey Smith    On 23 Nov, 2025    Comments (15)

blog-post-image

New antidepressants like Exxua, Auvelity, and Zuranolone offer faster relief and fewer side effects than traditional SSRIs. Discover how they work, who benefits most, and what to ask your doctor in 2025.

View More

Crossover Trial Design: How Bioequivalence Studies Are Structured

By Lindsey Smith    On 22 Nov, 2025    Comments (8)

blog-post-image

Crossover trial designs are the gold standard for bioequivalence studies, using each participant as their own control to reduce variability and sample size. Learn how 2x2 and replicate designs work, why washout periods matter, and what regulators require.

View More

Medications for Alcohol Use Disorder and the Hidden Risk of Relapse

By Lindsey Smith    On 20 Nov, 2025    Comments (15)

blog-post-image

Medications for alcohol use disorder can reduce relapse risk - but only when used correctly. Learn how naltrexone, acamprosate, and disulfiram work, why they sometimes fail, and what actually helps people stay sober.

View More

SSRIs and Opioids: Understanding Serotonin Syndrome Risk and How to Prevent It

By Lindsey Smith    On 16 Nov, 2025    Comments (13)

blog-post-image

Combining SSRIs and opioids can cause serotonin syndrome-a dangerous, sometimes fatal condition. Learn which opioid-SSRI pairs are risky, how to spot early symptoms, and what safer alternatives exist.

View More

How COVID-19 Disrupted Drug Availability and Created Lasting Shortages

By Lindsey Smith    On 16 Nov, 2025    Comments (13)

blog-post-image

COVID-19 caused severe drug shortages and made illegal drugs deadlier. Essential medications vanished, overdose deaths surged, and support systems collapsed. Here’s what happened-and why it still matters.

View More